United States
|
XAV939 (CAS: 284028-89-3)
|
| SKU-Pack Size | Availability | Size | Price | |
| EBC51062-1ML | In Stock | 1mL(10mM in DMSO) | $73.50 | |
| EBC51062-5MG | In Stock | 5mg | $58.50 | |
| EBC51062-10MG | In Stock | 10mg | $88.50 | |
| EBC51062-25MG | In Stock | 25mg | $163.50 | |
| EBC51062-50MG | In Stock | 50mg | $268.50 |
| Please Select The Country You Are In To Find Your Local Distributor. |
| EbioCell | Phone:(540) 808-3925 | |
| Imperial Business Park 4819 Emperor Boulevard, | E-mail:order@ebiocell.com | |
| United States | Suite 408 Durham, NC 27703, USA | Web:www.ebiocell.com |
| Product Information | |||||||||||||||||||||
| Synonym(s) | Tankyrase inhibitor, XAV 939, XAV-939, NVP-XAV939 | ||||||||||||||||||||
| Chemical Name | 2-[4-(trifluoromethyl)phenyl]-1,5,7,8-tetrahydrothiopyrano[4,3-d]pyrimidin-4-one | ||||||||||||||||||||
| Application | XAV939 is a potent inhibitor of beta-catenin, TNKS1, and TNKS2 | ||||||||||||||||||||
| CAS Number | 284028-89-3 | ||||||||||||||||||||
| Purity | ≥98.5% | ||||||||||||||||||||
| Molecular Weight | 312.31 | ||||||||||||||||||||
| Molecular Formula | C₁₄H₁₁F₃N₂OS | ||||||||||||||||||||
| SMILES | OC1=NC(C2=CC=C(C(F)(F)F)C=C2)=NC3=C1CSCC3 | ||||||||||||||||||||
| Target & IC50 | Tankyrase 1: IC50 = 11 nM Tankyrase 2: IC50 = 4 nM Protein Wnt-3a: IC50 = 51 nM Catenin beta-1: IC50 = 51 nM (human) |
||||||||||||||||||||
| Solubility | DMSO: 12 mg/mL (38.42 mM) | ||||||||||||||||||||
| Preparing Stock Solutions |
|
||||||||||||||||||||
| Shipping | Gel Pack | ||||||||||||||||||||
| Storage | Store at -20°C | ||||||||||||||||||||
| Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. | ||||||||||||||||||||
| Product Description | |
XAV939 is a potent, small molecule inhibitor of tankyrase 1 (TNKS) (IC50 = 11 nM) and tankyrase 2 (IC50 = 4 nM). By inhibiting TNKS activity, XAV939 increases the protein levels of the axin-GSK3β complex and promotes the degradation of β-catenin in SW480 cells. At concentrations as low as 0.3 μM, XAV939 inhibits colony formation of APC-deficient colorectal cancer cells. |
| Specific Protocols | |